dc.contributorPublic Library of Science
dc.creatorJuárez Montiel, Margarita
dc.creatorRomero Maldonado, Andrea
dc.creatorMonreal Escalante, Elizabeth
dc.creatorRosales Mendoza, Sergio
dc.creatorJiménez Bremont, Juan Francisco
dc.date2018-03-23T23:59:44Z
dc.date2018-03-23T23:59:44Z
dc.date2015-07
dc.date.accessioned2023-07-17T22:05:15Z
dc.date.available2023-07-17T22:05:15Z
dc.identifierJuárez-Montiel M, Romero-Maldonado A, Monreal-Escalante E, Becerra-Flora A, Korban SS, Rosales-Mendoza S, et al. (2015) The Corn Smut (‘Huitlacoche’) as a New Platform for Oral Vaccines. PLoS ONE 10(7): e0133535. https://doi.org/10.1371/journal.pone.0133535
dc.identifierhttp://hdl.handle.net/11627/3718
dc.identifierhttps://doi.org/10.1371/journal.pone.0133535
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7544310
dc.description"The development of new alternative platforms for subunit vaccine production is a priority in the biomedical field. In this study, Ustilago maydis, the causal agent of common corn smut or 'huitlacoche' has been genetically engineered to assess expression and immunogenicity of the B subunit of the cholera toxin (CTB), a relevant immunomodulatory agent in vaccinology. An oligomeric CTB recombinant protein was expressed in corn smut galls at levels of up to 1.3 mg g(-1) dry weight (0.8% of the total soluble protein). Mice orally immunized with 'huitlacoche'-derived CTB showed significant humoral responses that were well-correlated with protection against challenge with the cholera toxin (CT). These findings demonstrate the feasibility of using edible corn smut as a safe, effective, and low-cost platform for production and delivery of a subunit oral vaccine. The implications of this platform in the area of molecular pharming are discussed."
dc.formatapplication/pdf
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsAcceso Abierto
dc.subjectOTRAS ESPECIALIDADES TECNOLÓGICAS
dc.titleThe corn smut (‘Huitlacoche’) as a new latform for oral vaccines
dc.typearticle


Este ítem pertenece a la siguiente institución